We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+2.7%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$746M
AUM Growth
-$106M
Cap. Flow
-$67.1M
Cap. Flow %
-9%
Top 10 Hldgs %
44.28%
Holding
510
New
122
Increased
34
Reduced
59
Closed
238

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$49.5M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$21.8M
3
DIS icon
Walt Disney
DIS
+$16.1M
4
MSFT icon
Microsoft
MSFT
+$11M
5
TSM icon
TSMC
TSM
+$8.27M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 7.31%
2 Communication Services 4.95%
3 Technology 3.75%
4 Energy 1.57%
5 Healthcare 1.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZIO
226
CALL
DELISTED
VIZIO Holding Corp.
VZIO
$109K 0.01%
12,500
GCC icon
227
CALL
WisdomTree Enhanced Commodity Strategy Fund
GCC
$270M
$107K 0.01%
+5,000
New +$112K
TCDA
228
PUT
DELISTED
Tricida, Inc. Common Stock
TCDA
$105K 0.01%
+10,000
New +$109K
TBCH
229
Turtle Beach Corp
TBCH
$238M
$91.7K 0.01%
13,443
-49,557
-79% -$519K
DFS
230
DELISTED
Discover Financial Services
DFS
$90.9K 0.01%
1,000
GOSS icon
231
Gossamer Bio
GOSS
$101M
$89.8K 0.01%
7,500
AMPH icon
232
PUT
Amphastar Pharmaceuticals
AMPH
$907M
$84.3K 0.01%
3,000
-47,000
-94% -$1.53M
KMDA icon
233
Kamada
KMDA
$404M
$81.6K 0.01%
18,100
-3,900
-18% -$19K
HLLY icon
234
CALL
Holley
HLLY
$335M
$81K 0.01%
20,000
ORKA
235
Oruka Therapeutics
ORKA
$5.31B
$77.7K 0.01%
3,142
+1,250
+66% +$35.3K
FYBR
236
CALL
DELISTED
Frontier Communications
FYBR
$77.3K 0.01%
3,300
BMRN icon
237
CALL
BioMarin Pharmaceuticals
BMRN
$11.9B
$76.3K 0.01%
+900
New +$80.1K
NVCR icon
238
PUT
NovoCure
NVCR
$1.76B
$76K 0.01%
1,000
CCL icon
239
CALL
Carnival Corporation Ltd
CCL
$38.1B
$70.3K 0.01%
10,000
RUN icon
240
Sunrun
RUN
$2.26B
$69K 0.01%
+2,500
New +$77.8K
IEA
241
CALL
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$67.7K 0.01%
5,000
-10,000
-67% -$130K
AUPH icon
242
CALL
Aurinia Pharmaceuticals
AUPH
$1.95B
$67.7K 0.01%
9,000
FFAI
243
CALL
Faraday Future Intelligent Electric
FFAI
$11.8M
0
FND icon
244
Floor & Decor
FND
$6.03B
$63.2K 0.01%
900
-2,600
-74% -$209K
BNED icon
245
PUT
Barnes & Noble Education
BNED
$435M
$60K 0.01%
250
RCEL icon
246
CALL
Avita Medical
RCEL
$137M
$52.7K 0.01%
10,000
TCDA
247
CALL
DELISTED
Tricida, Inc. Common Stock
TCDA
$52.4K 0.01%
+5,000
New +$54.7K
LONA
248
PUT
LeonaBio Inc
LONA
$66.1M
$52K 0.01%
1,750
BHIL
249
CALL
DELISTED
Benson Hill, Inc.
BHIL
$46.3K 0.01%
483
ANY icon
250
CALL
Sphere 3D
ANY
$15.7M
$44.2K 0.01%
1,429

Similar funds

SG3 Management's Q3 2022 Portfolio in Review

As of Q3 2022, SG3 Management held 510 positions worth $746M, down 12% from $852M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

SG3 Management withdrew a net $67.1M in Q3 2022, closing 238 positions and reducing 59 holdings. Its most notable exit was KraneShares CSI China Internet ETF, an estimated $6.55M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 7.3% of assets, up from 0.21% a quarter earlier, followed by Communication Services and Technology.

Against the trend, SG3 Management opened a new position in Tesla worth $47M.

  • SG3 Management's largest Q3 2022 buy was Tesla: 177,200 shares worth $47M.
  • SG3 Management added most to Apellis Pharmaceuticals in Q3 2022, an estimated $2.3M increase.
  • SG3 Management's biggest Q3 2022 reduction was LivaNova, cutting an estimated $1.29M.
  • SG3 Management fully exited KraneShares CSI China Internet ETF in Q3 2022, selling an estimated $6.55M.
  • SG3 Management's ten largest holdings make up 44% of its $746M portfolio in Q3 2022.
  • SG3 Management opened 122 new positions and closed 238 in Q3 2022.
  • SG3 Management's portfolio value fell 12% quarter-over-quarter to $746M.

Based on SG3 Management's 13F filing for Q3 2022, filed 14 Nov 2022.